The Netherlands Cancer Institute — ERA-LEARN

Skip to content
Skip to footer

Service Navigation

Home
About
Contact
newsletter
Twitter

Main Menu Search

Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Home
Partnerships in a Nutshell
Explore Partnerships
Support for Partnerships
Documents
News and Events
- News
- Events

Evolution of resistant clones to novel target-directed drugs in colorectal tumors. - A genetic and epigenetic study of intratumoral heterogeneity dynamics

Home
Explore Partnerships
Partnerships
TRANSCAN-2
Joint Transnational Call for Proposals (JTC 2014)
Evolution of resistant clones to novel target-directed drugs in colorectal tumors. - A genetic and epigenetic study of intratumoral heterogeneity dynamics
The Netherlands Cancer Institute

Full name	The Netherlands Cancer Institute
Short name
Type of organisation
Partner Role	Partner
Country	Netherlands

Back to project overview

ERA-LEARN has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 811171.

Sitemap
Imprint
Privacy Policy
Submit accessibility issues
Accessibility Statement

Follow us on Twitter
@ERALEARN_EU

Use of cookies

We use cookies for statistical purposes and to remember your settings. Please check our privacy and cookies policy.